PaxMedica, Inc. Annual Operating Income (Loss) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PaxMedica, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
  • PaxMedica, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3M, a 10.7% increase year-over-year.
  • PaxMedica, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$15.4M, a 2.47% decline year-over-year.
  • PaxMedica, Inc. annual Operating Income (Loss) for 2023 was -$16.1M, a 52.3% decline from 2022.
  • PaxMedica, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 47.3% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$16.1M -$5.54M -52.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$10.6M -$3.41M -47.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$7.2M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.